Four-Gene Combo Might Predict Lethality Of Stomach Cancer

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

FRIDAY, April 25, 2025 — Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study says.

Testing for these genetic mutations could enable doctors to offer targeted treatments and spare some patients from going through aggressive measures like surgery or chemotherapy, researchers will argue at the upcoming medical conference in San Diego.

"Not all stomach cancers are equal,” lead researcher Dr. Ulysses Ribeiro, a professor at the São Paulo State Cancer Institute in Brazil, said in a news release.

“Today, most gastric cancers are treated the same way — with surgery and chemotherapy — but we hope to identify key molecular differences so we can tailor treatment to the biology of each patient’s tumor,” Ribeiro said.

For the study, researchers analyzed 21 genes in tumor samples taken from 87 patients who’d undergone surgery and chemo for stomach cancer.

The team then compared how mutations in these genes tracked with patients’ survival.

About one-third of patients had changes in a specific combination of four genes — BRCA2, CDH1, RHOA and TP53 – and those patients were more likely to die from their cancer or have it return, results show.

That genetic combo contained well-established cancer drivers like BRCA2 mutations, which have been linked to breast and ovarian cancer, as well as previously unknown genetic variants, researchers said.

Researchers are now working to match these findings to established lab tests that could make it easy and affordable to screen tumors for the identified high-risk genetic pattern.

“We believe that these findings move us closer to more personalized treatment based on each tumor’s biology,” Ribeiro said.

He is scheduled to present these findings at the Digestive Disease Week meeting on May 3. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed journal.

Sources

  • American Gastroenterological Association, news release, April 25, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-26 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords